Orazephin®
INDICATION: Antibacterial
Orazephin® CR is an oral version of a widely used intravenous antibiotic Ceftriaxone.
Discover Orazephin®
Overview
Ceftriaxone is currently one of the most important and effective broad spectrum antibiotics used to treat over ten different infectious diseases including meningitis and post-surgical prophylaxis.
Phase
Orazephin® CR is currently in Phase I clinical trial.
US Market ($B USD)
The estimated market for Orazephin® in the United States is $0.75 Billion USD.
Global Market ($B USD)
The estimated market for Orazephin® globally is $1.3 Billion USD.